HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satisfactory remission achieved by PUVA therapy in Langerhans cell hisiocytosis in an elderly patient.

Abstract
Langerhans cell histiocytosis is currently regarded as a reactive proliferative process of Langerhans cells rather than a malignancy. The disease is characterized by Langerhans cell infiltration of skin, lung, bone and other organs. We report a 74-year-old man with Langerhans cell histiocytosis who had generalized hemorrhagic and crusted papules. He also had diabetes insipidus. Because he did not have any severe constitutional symptoms or failure of vital organs, we applied topical PUVA treatment to his skin lesions, which responded well to the therapy. Diabetes insipidus, however, remained, in spite of X ray radiotherapy for the pituitary lesion.
AuthorsH Sakai, M Ibe, H Takahashi, S Matsuo, K Okamoto, I Makino, Y Oomori, H Iizuka
JournalThe Journal of dermatology (J Dermatol) Vol. 23 Issue 1 Pg. 42-6 (Jan 1996) ISSN: 0385-2407 [Print] England
PMID8720257 (Publication Type: Case Reports, Journal Article)
Topics
  • Aged
  • Diabetes Insipidus (complications, radiotherapy)
  • Epidermis (pathology)
  • Histiocytosis, Langerhans-Cell (complications, drug therapy, pathology)
  • Humans
  • Male
  • PUVA Therapy
  • Remission Induction
  • Skin Diseases, Papulosquamous (complications, drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: